Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Specific delivery of microRNA93 into HBV-replicating hepatocytes downregulates protein expression of liver cancer susceptible gene MICA.

Ohno M, Otsuka M, Kishikawa T, Shibata C, Yoshikawa T, Takata A, Muroyama R, Kowatari N, Sato M, Kato N, Kuroda S, Koike K.

Oncotarget. 2014 Jul 30;5(14):5581-90.

2.

Safety and efficacy of lamivudine after radiofrequency ablation in patients with hepatitis B virus-related hepatocellular carcinoma.

Yoshida H, Yoshida H, Goto E, Sato T, Ohki T, Masuzaki R, Tateishi R, Goto T, Shiina S, Kawabe T, Omata M.

Hepatol Int. 2008 Mar;2(1):89-94. doi: 10.1007/s12072-007-9020-7. Epub 2007 Sep 26.

3.

Antiviral activity, dose-response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial.

Shindo M, Chayama K, Mochida S, Toyota J, Tomita E, Kumada H, Yokosuka O, Sata M, Hayashi N, Suzuki K, Okanoue T, Tsubouchi H, Ishikawa H, Seriu T, Omata M.

Hepatol Int. 2009 Sep;3(3):445-52. doi: 10.1007/s12072-009-9135-0. Epub 2009 May 23.

4.

Rapid quantification of hepatitis B virus DNA by real-time PCR using efficient TaqMan probe and extraction of virus DNA.

Lu YQ, Han JX, Qi P, Xu W, Zu YH, Zhu B.

World J Gastroenterol. 2006 Dec 7;12(45):7365-70.

6.

Novel nucleoside analogue MCC-478 (LY582563) is effective against wild-type or lamivudine-resistant hepatitis B virus.

Ono-Nita SK, Kato N, Shiratori Y, Carrilho FJ, Omata M.

Antimicrob Agents Chemother. 2002 Aug;46(8):2602-5.

7.

The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance.

Ono SK, Kato N, Shiratori Y, Kato J, Goto T, Schinazi RF, Carrilho FJ, Omata M.

J Clin Invest. 2001 Feb;107(4):449-55.

8.

Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors.

Ono-Nita SK, Kato N, Shiratori Y, Lan KH, Yoshida H, Carrilho FJ, Omata M.

J Clin Invest. 1999 Jun;103(12):1635-40.

Items per page

Supplemental Content

Write to the Help Desk